BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34323194)

  • 1. Anaphylaxis to Pantoprazole: A Case Report and Prerequisite for Vigilant Prescribing Practises for Proton Pump Inhibitors.
    James J; Rani J; Sathyanarayanan V; Begum A; Fayaz SH
    Curr Drug Saf; 2022; 17(1):78-80. PubMed ID: 34323194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples].
    Dohr J; Hunzelmann N; Brown A
    Hautarzt; 2018 Feb; 69(2):162-164. PubMed ID: 29085952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.
    Gouraud A; Vochelle V; Descotes J; Vial T
    Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative.
    Turedi O; Sozener ZC; Kendirlinan R; Bavbek S
    Curr Drug Saf; 2017; 12(3):198-200. PubMed ID: 28699491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis to pantoprazole during general anesthesia.
    Lai HC; Hsu SW; Lu CH; Ma HI; Cherng CH; Hung NK; Wu CT
    J Anesth; 2011 Aug; 25(4):606-8. PubMed ID: 21626263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.
    van der Zalm IJB; Tobé TJM; Logtenberg SJJ
    J Med Case Rep; 2020 Jun; 14(1):83. PubMed ID: 32594911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
    Escoffier J; Arnaud B; Kaba M; Hograindleur JP; Le Blévec E; Martinez G; Stévant I; Ray PF; Arnoult C; Nef S
    Andrology; 2020 Nov; 8(6):1795-1804. PubMed ID: 32609951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic reactions to proton-pump inhibitors.
    Natsch S; Vinks MH; Voogt AK; Mees EB; Meyboom RH
    Ann Pharmacother; 2000 Apr; 34(4):474-6. PubMed ID: 10772433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis to Commonly Used Drug Oral Pantoprazole.
    Sharda M; Mittal SK; Gadhwal M; Vijay A
    J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355982
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonallergic anaphylaxis to pantoprazole.
    Kaatz M; Bauer A; Hipler C; Elsner P
    Allergy; 2002 Feb; 57(2):184. PubMed ID: 11929432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Proton Pump Inhibitors and Microscopic Colitis.
    Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
    Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver hepatotoxicity associated with pantoprazole: a rare case report.
    Aslan M; Celik Y; Karadas S; Olmez S; Cifci A
    Wien Klin Wochenschr; 2014 Jun; 126(11-12):390-2. PubMed ID: 24652021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study.
    Vovolis V; Koutsostathis N; Stefanaki E
    Allergy; 2008 Sep; 63(9):1251-2. PubMed ID: 18699945
    [No Abstract]   [Full Text] [Related]  

  • 17. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
    Martin RM; Dunn NR; Freemantle S; Shakir S
    Br J Clin Pharmacol; 2000 Oct; 50(4):366-72. PubMed ID: 11012560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Pantoprazole-Induced Near Fatality.
    Nand N; Dsouza S; Batra N; Chauhan V; Yadav M
    J Assoc Physicians India; 2015 Jun; 63(6):96. PubMed ID: 26710417
    [No Abstract]   [Full Text] [Related]  

  • 19. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.
    Lobera T; Navarro B; Del Pozo MD; González I; Blasco A; Escudero R; Venturini M; Alarcón E
    J Investig Allergol Clin Immunol; 2009; 19(1):57-60. PubMed ID: 19274931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.